CAS 863288-34-0

CJC 1295

Descrição:

CJC-1295 é um peptídeo sintético que funciona como um análogo do hormônio liberador de hormônio de crescimento (GHRH). É utilizado principalmente em ambientes de pesquisa para estudar seus efeitos na secreção de hormônio de crescimento e possíveis aplicações terapêuticas. CJC-1295 é caracterizado por sua capacidade de estimular a glândula pituitária a liberar hormônio de crescimento, o que pode levar ao aumento da massa muscular, perda de gordura e melhora na recuperação. O peptídeo tem uma longa meia-vida devido à sua modificação, o que permite uma liberação sustentada e atividade prolongada no corpo. Geralmente é administrado por injeção subcutânea. CJC-1295 é frequentemente estudado no contexto do anti-envelhecimento, musculação e distúrbios metabólicos, embora seu uso em humanos fora da pesquisa não seja aprovado por agências reguladoras. Assim como com qualquer peptídeo, a pureza, dosagem e via de administração são críticas para sua eficácia e segurança. Os pesquisadores devem aderir a diretrizes éticas e regulatórias ao manusear e estudar este composto.

Fórmula: Unspecified

Sinónimos:

• <span class="text-smallcaps">L</smallcap>-Lysinamide, <smallcap>L</smallcap>-tyrosyl-<smallcap>D</smallcap>-alanyl-<smallcap>L</smallcap>-α-aspartyl-<smallcap>L</smallcap>-alanyl-<smallcap>L</smallcap>-isoleucyl-<smallcap>L</smallcap>-phenylalanyl-<smallcap>L</smallcap>-threonyl-<smallcap>L</smallcap>-glutaminyl-<smallcap>L</smallcap>-seryl-<smallcap>L</smallcap>-tyrosyl-<smallcap>L</smallcap>-arginyl-<smallcap>L</smallcap>-lysyl-<smallcap>L</smallcap>-valyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-alanyl-<smallcap>L</smallcap>-glutaminyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-seryl-<smallcap>L</smallcap>-alanyl-<smallcap>L</smallcap>-arginyl-<smallcap>L</smallcap>-lysyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-glutaminyl-<smallcap>L</smallcap>-α-aspartyl-<smallcap>L</smallcap>-isoleucyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-seryl-<smallcap>L</span>-arginyl-N⁶-[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]-
• <span class="text-smallcaps">L</smallcap>-Tyrosyl-<smallcap>D</smallcap>-alanyl-<smallcap>L</smallcap>-α-aspartyl-<smallcap>L</smallcap>-alanyl-<smallcap>L</smallcap>-isoleucyl-<smallcap>L</smallcap>-phenylalanyl-<smallcap>L</smallcap>-threonyl-<smallcap>L</smallcap>-glutaminyl-<smallcap>L</smallcap>-seryl-<smallcap>L</smallcap>-tyrosyl-<smallcap>L</smallcap>-arginyl-<smallcap>L</smallcap>-lysyl-<smallcap>L</smallcap>-valyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-alanyl-<smallcap>L</smallcap>-glutaminyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-seryl-<smallcap>L</smallcap>-alanyl-<smallcap>L</smallcap>-arginyl-<smallcap>L</smallcap>-lysyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-glutaminyl-<smallcap>L</smallcap>-α-aspartyl-<smallcap>L</smallcap>-isoleucyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-seryl-<smallcap>L</smallcap>-arginyl-N⁶-[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]-<smallcap>L</span>-lysinamide
• Cjc 1295
• L-Tyrosyl-D-alanyl-L-α-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-glutaminyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucyl-L-alanyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-isoleucyl-L-leucyl-L-seryl-L-arginyl-N6-[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]-L-lysinamide
• L-Lysinamide, L-tyrosyl-D-alanyl-L-α-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-glutaminyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucyl-L-alanyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-isoleucyl-L-leucyl-L-seryl-L-arginyl-N6-[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]-

CJC-1295

CAS: 863288-34-0

Fórmula: C₁₅₂H₂₅₂N₄₄O₄₂

Pureza: 95%~99%

Cor e Forma: White to Off-white Powder

Peso molecular: 3367.897

Ref: BP-BPPG019

CJC-1295

CAS: 863288-34-0

CJC-1295 is a synthetic peptide, which is an analogue of growth hormone-releasing hormone (GHRH). It is synthesized through recombinant DNA technology, which allows for precise control over its sequence and length. This particular peptide is designed to bind to GHRH receptors in the pituitary gland. By activating these receptors, CJC-1295 stimulates the release of growth hormone (GH) into the bloodstream.The primary function of CJC-1295 is to influence the endocrine system, particularly enhancing the release of endogenous growth hormone. It achieves this by increasing the amplitude and frequency of GH pulses without affecting the natural negative feedback mechanisms that regulate GH production. This mode of action distinguishes CJC-1295 from other growth hormone therapies, as it promotes a more physiological pattern of hormone secretion.CJC-1295 is used in various scientific contexts, primarily in research focusing on growth hormone deficiencies, muscle wasting conditions, and certain metabolic disorders. Its ability to increase GH release also makes it a subject of interest in studies related to aging, tissue repair, and regeneration. The longer half-life of CJC-1295 compared to natural GHRH peptides further enhances its applications in research, allowing for more sustained and controlled experimentation.

Pureza: Min. 95%

Ref: 3D-FC138107